News & Updates

Treatment with mifepristone significantly reduced HbA_1c levels in patients with difficult-to-control type 2 diabetes (T2D) and hypercortisolism compared with placebo, according to the final results of the CATALYST trial presented at ADA 2025.

Effective antiviral therapy is crucial for achieving sustained viral clearance and improving outcomes in patients with COVID-19, particularly among immunocompromised individuals.

At the recent ESCMID Global 2025 in Vienna, Austria, Ruth Mokgokong, a pharmacologist at Pfizer, UK, presented findings from the EPIC-IC trial, highlighting the benefits of an extended nirmatrelvir-ritonavir regimen in severely immunocompromised patients with symptomatic COVID-19.

A recent study has shown the significant role that BMI plays in the relationship between food insecurity and diabetes.

Early weight loss associated with the use of tirzepatide may significantly improve cardiometabolic health, particularly in adults achieving a normal BMI by week 52, according to a China study.

The first type 1 diabetes (T1D) genetic risk score (GRS) tailored for the Chinese population, developed by a joint research team from The Chinese University of Hong Kong’s (CUHK), the UK and China, signifies a leap forward in correct diagnosis of diabetes.

Patients with type 2 diabetes (T2D) and nonproliferative diabetic retinopathy (NPDR) who undergo modern cataract surgery tend to progress to proliferative diabetic retinopathy (PDR) within a year after the procedure, reveals a recent study.

A low-fat vegan diet yields a significant reduction in dietary acid load compared with the Mediterranean diet, and this alkalizing effect is associated with weight loss in overweight adults, according to the results of a cross-over study.